ACET
Price
$0.60
Change
-$0.00 (-0.00%)
Updated
Apr 24, 12:10 PM (EDT)
Capitalization
48.1M
26 days until earnings call
TEVA
Price
$14.29
Change
+$0.29 (+2.07%)
Updated
Apr 23 closing price
Capitalization
15.06B
13 days until earnings call
Ad is loading...

ACET vs TEVA

Header iconACET vs TEVA Comparison
Open Charts ACET vs TEVABanner chart's image
Adicet Bio
Price$0.60
Change-$0.00 (-0.00%)
Volume$413
Capitalization48.1M
Teva Pharmaceutical Industries
Price$14.29
Change+$0.29 (+2.07%)
Volume$10.7M
Capitalization15.06B
ACET vs TEVA Comparison Chart
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. TEVA commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and TEVA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ACET: $0.62 vs. TEVA: $14.29)
Brand notoriety: ACET: Not notable vs. TEVA: Notable
ACET represents the Biotechnology, while TEVA is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 38% vs. TEVA: 87%
Market capitalization -- ACET: $48.1M vs. TEVA: $15.06B
ACET [@Biotechnology] is valued at $48.1M. TEVA’s [@Pharmaceuticals: Other] market capitalization is $15.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileTEVA’s FA Score has 1 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • TEVA’s FA Score: 1 green, 4 red.
According to our system of comparison, TEVA is a better buy in the long-term than ACET.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 4 TA indicator(s) are bullish while TEVA’s TA Score has 6 bullish TA indicator(s).

  • ACET’s TA Score: 4 bullish, 5 bearish.
  • TEVA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TEVA is a better buy in the short-term than ACET.

Price Growth

ACET (@Biotechnology) experienced а +7.82% price change this week, while TEVA (@Pharmaceuticals: Other) price change was +6.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.69%. For the same industry, the average monthly price growth was -6.37%, and the average quarterly price growth was -12.69%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.96%. For the same industry, the average monthly price growth was -6.07%, and the average quarterly price growth was -9.98%.

Reported Earning Dates

ACET is expected to report earnings on Aug 06, 2025.

TEVA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (+2.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TEVA($15.1B) has a higher market cap than ACET($48.1M). TEVA (-35.163) and ACET (-35.967) have similar YTD gains . TEVA has higher annual earnings (EBITDA): 1.56B vs. ACET (-110.65M). TEVA has more cash in the bank: 3.23B vs. ACET (176M). ACET has less debt than TEVA: ACET (17.2M) vs TEVA (20.2B). TEVA has higher revenues than ACET: TEVA (15.8B) vs ACET (0).
ACETTEVAACET / TEVA
Capitalization48.1M15.1B0%
EBITDA-110.65M1.56B-7%
Gain YTD-35.967-35.163102%
P/E RatioN/A22.62-
Revenue015.8B-
Total Cash176M3.23B5%
Total Debt17.2M20.2B0%
FUNDAMENTALS RATINGS
ACET vs TEVA: Fundamental Ratings
ACET
TEVA
OUTLOOK RATING
1..100
921
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
72
Overvalued
PROFIT vs RISK RATING
1..100
10050
SMR RATING
1..100
9593
PRICE GROWTH RATING
1..100
9464
P/E GROWTH RATING
1..100
1410
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (36) in the Medical Distributors industry is somewhat better than the same rating for TEVA (72) in the Pharmaceuticals Generic industry. This means that ACET’s stock grew somewhat faster than TEVA’s over the last 12 months.

TEVA's Profit vs Risk Rating (50) in the Pharmaceuticals Generic industry is somewhat better than the same rating for ACET (100) in the Medical Distributors industry. This means that TEVA’s stock grew somewhat faster than ACET’s over the last 12 months.

TEVA's SMR Rating (93) in the Pharmaceuticals Generic industry is in the same range as ACET (95) in the Medical Distributors industry. This means that TEVA’s stock grew similarly to ACET’s over the last 12 months.

TEVA's Price Growth Rating (64) in the Pharmaceuticals Generic industry is in the same range as ACET (94) in the Medical Distributors industry. This means that TEVA’s stock grew similarly to ACET’s over the last 12 months.

TEVA's P/E Growth Rating (10) in the Pharmaceuticals Generic industry is in the same range as ACET (14) in the Medical Distributors industry. This means that TEVA’s stock grew similarly to ACET’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETTEVA
RSI
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
66%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
71%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 21 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
61%
View a ticker or compare two or three
Ad is loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FBIO1.580.05
+3.27%
Fortress Biotech
HRTX2.200.05
+2.33%
Heron Therapeutics
VFC11.110.20
+1.83%
VF Corp
PYPL62.461.04
+1.69%
PayPal Holdings
LILAK5.380.08
+1.51%
Liberty Latin America Ltd

TEVA and

Correlation & Price change

A.I.dvisor tells us that TEVA and AMRX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TEVA and AMRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
+2.07%
AMRX - TEVA
33%
Poorly correlated
+0.69%
PCRX - TEVA
28%
Poorly correlated
-1.02%
ELAN - TEVA
26%
Poorly correlated
+3.37%
SNDL - TEVA
26%
Poorly correlated
+1.79%
ACET - TEVA
25%
Poorly correlated
+5.90%
More